Evolutionary Qβ Phage Displayed Nanotag Library and Peptides for Biosensing

Puzzling Peptides from a Phage Display Library

The commercial availability of random peptide libraries displayed on the M13 phage is increasing their use forstudies on epitope identification, enzyme inhibitors, receptor ligands, etc. In this study two experimentswhere planned for selection of peptides. First with sheep antibodies, the positive selector was IgG, preparedon Protein G column from a pool of 11 sheeps immunized...

Identifying reactive peptides from phage-displayed libraries.

Phage display enables the synthesis, selection, and screening of large, polypeptide libraries (>1 × 10(10) different members). Selections from such libraries can identify binding partners to essentially any desired target (Sarikaya et al., Annu Rev Mater Res 34:373-408, 2004; Deutscher, Chem Rev 110:3196-3211, 2010). Peptides with affinity or reactivity to small molecule probes are attractive f...

Antibody and Antigen Binding Peptides Using a Phage Displayed Random Peptide Library

Dihydrofolate Reductase Inhibitory Peptides Screened from Structured Design -Loop Peptide Library Displayed on Phage

Experimental section General All chemicals and solvents for peptide synthesis were of reagent or HPLC grade and were used without further purification. TARON resin was purchased from Clontech. Dihydrofolate (DHP), nicotinamide adenine dinucleotide phosphate (NADPH) and methotrexate (MTX) were purchased from Wako Pure Chemical Industries. Biotin-AC5-OSu and 2-morpholinoethanesulfonic acid monohy...

Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library

OBJECTIVE Vascular endothelial growth factor (VEGF) interaction with its receptor, VEGFR-3/Flt-4, regulates lymphangiogenesis. VEGFR-3/Flt-4 expression in cancer cells has been correlated with clinical stage, lymph node metastasis, and lymphatic invasion. The objective of this study is to identify a VEGFR-3/Flt-4-interacting peptide that could be used to inhibit VEGFR-3 for ovarian cancer thera...